NCT03705338

Brief Summary

Anesthesia is essential to control pain and produce unconsciousness during surgery and other procedures during childhood. The anesthetic deepness is measured indirectly through changes in blood pressure and heart rate or can be inferred according to estimated or measured concentrations of anesthetics. In adults, anesthetic dosing, using patterns based on electroencephalogram (EEG) analysis, has shown clinical advantages compared to traditional monitoring. These advantages include lower consumption of hypnotics, less post-operative cognitive deterioration and decreased intraoperative awakening. The maturation of the brain and Central Nervous System (CNS) that occurs in childhood affects the response of anesthetics. Additionally, the EEG changes with age and its dominant frequency is lower in children. This explains why brain monitoring methods developed in adults do not work well in children. However, these patterns cannot be extrapolated to the pediatric population. Therefore, it is necessary to develop indexes based on EEG with pediatric data to improve the dosage of hypnotics in this population. The appearance of alpha wave in frontal EEG has been successfully used as a marker of unconsciousness during general anesthesia with GABAergic hypnotics in adults (sevoflurane, propofol). However, in children, the alpha wave appears since 4 months of age in anesthetics with sevoflurane, so studying the characterization of this wave during the loss and recovery of secondary consciousness anesthetic agents such as propofol has not been studied yet.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 15, 2018

Completed
2.4 years until next milestone

Study Start

First participant enrolled

March 15, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2021

Completed
Last Updated

March 8, 2022

Status Verified

March 1, 2022

Enrollment Period

7 months

First QC Date

October 5, 2018

Last Update Submit

March 7, 2022

Conditions

Keywords

AnesthesiaChildrenElectroencephalographyPropofol

Outcome Measures

Primary Outcomes (3)

  • Loss and Recovery of consciousness

    Recorded by the EEG signal - 40 channels waves: Beta, Alpha,Theta

    Continuously from start of propofol infusion to unarousable up to ending of infusion arouses without stimuli. In average 2 hrs.

  • Recovery of consciousness

    Watching the awakening and/or gross movement. Recorded by Go Pro cam the moment of Recovery of consciousness.

    From to ending of propofol infusion to arouses without stimuli. Continuously for 10 min.

  • Loss of consciousness

    Level 4 of University of Michigan Sedation Scale for children \[0 0=awake/alert; 1=sleepy/responds appropriately; 2=somnolent/arouses to light stimuli ; 3=deep sleep/arouses to deeper physical stimuli; 4=unarousable to stimuli\]. Recorded by Go Pro cam the moment of loss consciousness.

    From start of propofol infusion to unarousable to stimuli. Continuously for 10 min.

Secondary Outcomes (3)

  • Arterial Pressure

    Entering operating room every 1 min per 5 min and every 5 min up to end of anesthesia or recovery of consciousness. In average 2 hrs.

  • Heart Rate

    Entering operating room every 1 min per 5 min and every 5 min up to end of anesthesia or recovery of consciousness. In average 2 hrs.

  • Saturation Oxigen

    Entering operating room every 1 min per 5 min and every 5 min up to end of anesthesia or recovery of consciousness. In average 2 hrs.

Study Arms (1)

Electroencephalography

Electroencephalography (EEG) for induction and emergence in pediatric patients under general anesthesia with propofol.

Device: ElectroencephalographyDrug: Propofol

Interventions

Measure the appearance and disappearance of frontal alpha wave with EE, when them loss and recovery of consciousness under general anesthesia with propofol.

Electroencephalography

Recorder the loss and recovery of consciousness in children under general anesthesia with TCI of propofol intravenous. Induction will be started with 20 mg/kg/hr of propofol up to UMSS level 4. Then will be titrated leading anesthesiologist criteria.

Also known as: General anesthetic
Electroencephalography

Eligibility Criteria

Age3 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with indications of surgery under general anesthesia and regional analgesia.

You may qualify if:

  • ASA I - II
  • Indications of phimosis surgery, cryptorchid and/or inguinal hernia surgery

You may not qualify if:

  • Anatomical limitations for installing the EEG cap.
  • Congenital or genetic malformations that influence his/her brain development.
  • Neurological or cardiovascular disease
  • Use of drugs with effect in the CNS in the last 24 hrs.
  • Preterm newborn less than 32 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Victor Contreras

Santiago, Santiago Metropolitan, 8420525, Chile

Location

Related Publications (7)

  • Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Tremper K, Naughton N. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth. 2002 Feb;88(2):241-5. doi: 10.1093/bja/88.2.241.

    PMID: 11878656BACKGROUND
  • Cornelissen L, Donado C, Lee JM, Liang NE, Mills I, Tou A, Bilge A, Berde CB. Clinical signs and electroencephalographic patterns of emergence from sevoflurane anaesthesia in children: An observational study. Eur J Anaesthesiol. 2018 Jan;35(1):49-59. doi: 10.1097/EJA.0000000000000739.

    PMID: 29120939BACKGROUND
  • Purdon PL, Pierce ET, Mukamel EA, Prerau MJ, Walsh JL, Wong KF, Salazar-Gomez AF, Harrell PG, Sampson AL, Cimenser A, Ching S, Kopell NJ, Tavares-Stoeckel C, Habeeb K, Merhar R, Brown EN. Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1142-51. doi: 10.1073/pnas.1221180110. Epub 2013 Mar 4.

    PMID: 23487781BACKGROUND
  • Brown EN, Purdon PL, Van Dort CJ. General anesthesia and altered states of arousal: a systems neuroscience analysis. Annu Rev Neurosci. 2011;34:601-28. doi: 10.1146/annurev-neuro-060909-153200.

    PMID: 21513454BACKGROUND
  • Cornelissen L, Bergin AM, Lobo K, Donado C, Soul JS, Berde CB. Electroencephalographic discontinuity during sevoflurane anesthesia in infants and children. Paediatr Anaesth. 2017 Mar;27(3):251-262. doi: 10.1111/pan.13061. Epub 2017 Feb 8.

    PMID: 28177176BACKGROUND
  • Cornelissen L, Kim SE, Purdon PL, Brown EN, Berde CB. Age-dependent electroencephalogram (EEG) patterns during sevoflurane general anesthesia in infants. Elife. 2015 Jun 23;4:e06513. doi: 10.7554/eLife.06513.

    PMID: 26102526BACKGROUND
  • Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016 Jan;122(1):234-42. doi: 10.1213/ANE.0000000000000989.

    PMID: 26418126BACKGROUND

MeSH Terms

Interventions

ElectroencephalographyPropofolAnesthetics, General

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Win Tin Chang

    Pontificia Universidad Catolica de Chile

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Co-Investigator. Project Manager of Department of Anesthesiology

Study Record Dates

First Submitted

October 5, 2018

First Posted

October 15, 2018

Study Start

March 15, 2021

Primary Completion

October 15, 2021

Study Completion

October 15, 2021

Last Updated

March 8, 2022

Record last verified: 2022-03

Locations